COVID-19 Impact on Global Autologous Cell Therapy Market Size, Status and Forecast 2020-2026

July 2020 | 90 pages | ID: C897679A8ADAEN
QYResearch

Abstracts

This report focuses on the global Autologous Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autologous Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• BioTime
• Pharmicell
• BrainStorm Cell Therapeutics
• Opexa Therapeutics
• Vericel Corporation
• Regeneus

Market segment by Type, the product can be split into

• Bone Marrow
• Epidermis

Market segment by Application, split into

• Neurology
• Orthopedics
• Cancer
• Wound Healing
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Autologous Cell Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Autologous Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Autologous Cell Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autologous Cell Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Autologous Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Bone Marrow
  1.4.3 Epidermis
1.5 Market by Application
  1.5.1 Global Autologous Cell Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Neurology
  1.5.3 Orthopedics
  1.5.4 Cancer
  1.5.5 Wound Healing
  1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Autologous Cell Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Autologous Cell Therapy Industry
    1.6.1.1 Autologous Cell Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Autologous Cell Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Autologous Cell Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Autologous Cell Therapy Market Perspective (2015-2026)
2.2 Autologous Cell Therapy Growth Trends by Regions
  2.2.1 Autologous Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Autologous Cell Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Autologous Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Autologous Cell Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Autologous Cell Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Autologous Cell Therapy Players by Market Size
  3.1.1 Global Top Autologous Cell Therapy Players by Revenue (2015-2020)
  3.1.2 Global Autologous Cell Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Autologous Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autologous Cell Therapy Market Concentration Ratio
  3.2.1 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Autologous Cell Therapy Revenue in 2019
3.3 Autologous Cell Therapy Key Players Head office and Area Served
3.4 Key Players Autologous Cell Therapy Product Solution and Service
3.5 Date of Enter into Autologous Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Autologous Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Autologous Cell Therapy Forecasted Market Size by Type (2021-2026)

5 AUTOLOGOUS CELL THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Autologous Cell Therapy Market Size by Application (2015-2020)
5.2 Global Autologous Cell Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Autologous Cell Therapy Market Size (2015-2020)
6.2 Autologous Cell Therapy Key Players in North America (2019-2020)
6.3 North America Autologous Cell Therapy Market Size by Type (2015-2020)
6.4 North America Autologous Cell Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Autologous Cell Therapy Market Size (2015-2020)
7.2 Autologous Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Autologous Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Autologous Cell Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Autologous Cell Therapy Market Size (2015-2020)
8.2 Autologous Cell Therapy Key Players in China (2019-2020)
8.3 China Autologous Cell Therapy Market Size by Type (2015-2020)
8.4 China Autologous Cell Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Autologous Cell Therapy Market Size (2015-2020)
9.2 Autologous Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Autologous Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Autologous Cell Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Autologous Cell Therapy Market Size (2015-2020)
10.2 Autologous Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autologous Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Autologous Cell Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Autologous Cell Therapy Market Size (2015-2020)
11.2 Autologous Cell Therapy Key Players in India (2019-2020)
11.3 India Autologous Cell Therapy Market Size by Type (2015-2020)
11.4 India Autologous Cell Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Autologous Cell Therapy Market Size (2015-2020)
12.2 Autologous Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Autologous Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Autologous Cell Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 BioTime
  13.1.1 BioTime Company Details
  13.1.2 BioTime Business Overview and Its Total Revenue
  13.1.3 BioTime Autologous Cell Therapy Introduction
  13.1.4 BioTime Revenue in Autologous Cell Therapy Business (2015-2020))
  13.1.5 BioTime Recent Development
13.2 Pharmicell
  13.2.1 Pharmicell Company Details
  13.2.2 Pharmicell Business Overview and Its Total Revenue
  13.2.3 Pharmicell Autologous Cell Therapy Introduction
  13.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2015-2020)
  13.2.5 Pharmicell Recent Development
13.3 BrainStorm Cell Therapeutics
  13.3.1 BrainStorm Cell Therapeutics Company Details
  13.3.2 BrainStorm Cell Therapeutics Business Overview and Its Total Revenue
  13.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Introduction
  13.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020)
  13.3.5 BrainStorm Cell Therapeutics Recent Development
13.4 Opexa Therapeutics
  13.4.1 Opexa Therapeutics Company Details
  13.4.2 Opexa Therapeutics Business Overview and Its Total Revenue
  13.4.3 Opexa Therapeutics Autologous Cell Therapy Introduction
  13.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020)
  13.4.5 Opexa Therapeutics Recent Development
13.5 Vericel Corporation
  13.5.1 Vericel Corporation Company Details
  13.5.2 Vericel Corporation Business Overview and Its Total Revenue
  13.5.3 Vericel Corporation Autologous Cell Therapy Introduction
  13.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2015-2020)
  13.5.5 Vericel Corporation Recent Development
13.6 Regeneus
  13.6.1 Regeneus Company Details
  13.6.2 Regeneus Business Overview and Its Total Revenue
  13.6.3 Regeneus Autologous Cell Therapy Introduction
  13.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2015-2020)
  13.6.5 Regeneus Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Autologous Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Autologous Cell Therapy Revenue
Table 3. Ranking of Global Top Autologous Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autologous Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bone Marrow
Table 6. Key Players of Epidermis
Table 7. COVID-19 Impact Global Market: (Four Autologous Cell Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Autologous Cell Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Autologous Cell Therapy Players to Combat Covid-19 Impact
Table 12. Global Autologous Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Autologous Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Autologous Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Autologous Cell Therapy Market Share by Regions (2015-2020)
Table 16. Global Autologous Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Autologous Cell Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Autologous Cell Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Autologous Cell Therapy Players
Table 23. Global Autologous Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Autologous Cell Therapy Market Share by Players (2015-2020)
Table 25. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Cell Therapy as of 2019)
Table 26. Global Autologous Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Autologous Cell Therapy Product Solution and Service
Table 29. Date of Enter into Autologous Cell Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Autologous Cell Therapy Market Size Share by Type (2015-2020)
Table 33. Global Autologous Cell Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Autologous Cell Therapy Market Size Share by Application (2015-2020)
Table 35. Global Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Autologous Cell Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 39. North America Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Autologous Cell Therapy Market Share by Type (2015-2020)
Table 41. North America Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Autologous Cell Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 45. Europe Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Autologous Cell Therapy Market Share by Type (2015-2020)
Table 47. Europe Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Autologous Cell Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 51. China Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Autologous Cell Therapy Market Share by Type (2015-2020)
Table 53. China Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Autologous Cell Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 57. Japan Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Autologous Cell Therapy Market Share by Type (2015-2020)
Table 59. Japan Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Autologous Cell Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 63. Southeast Asia Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Autologous Cell Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Autologous Cell Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 69. India Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Autologous Cell Therapy Market Share by Type (2015-2020)
Table 71. India Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Autologous Cell Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Autologous Cell Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Autologous Cell Therapy Market Share (2019-2020)
Table 75. Central & South America Autologous Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Autologous Cell Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Autologous Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Autologous Cell Therapy Market Share by Application (2015-2020)
Table 79. BioTime Company Details
Table 80. BioTime Business Overview
Table 81. BioTime Product
Table 82. BioTime Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 83. BioTime Recent Development
Table 84. Pharmicell Company Details
Table 85. Pharmicell Business Overview
Table 86. Pharmicell Product
Table 87. Pharmicell Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 88. Pharmicell Recent Development
Table 89. BrainStorm Cell Therapeutics Company Details
Table 90. BrainStorm Cell Therapeutics Business Overview
Table 91. BrainStorm Cell Therapeutics Product
Table 92. BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 93. BrainStorm Cell Therapeutics Recent Development
Table 94. Opexa Therapeutics Company Details
Table 95. Opexa Therapeutics Business Overview
Table 96. Opexa Therapeutics Product
Table 97. Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 98. Opexa Therapeutics Recent Development
Table 99. Vericel Corporation Company Details
Table 100. Vericel Corporation Business Overview
Table 101. Vericel Corporation Product
Table 102. Vericel Corporation Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 103. Vericel Corporation Recent Development
Table 104. Regeneus Company Details
Table 105. Regeneus Business Overview
Table 106. Regeneus Product
Table 107. Regeneus Revenue in Autologous Cell Therapy Business (2015-2020) (Million US$)
Table 108. Regeneus Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Autologous Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Bone Marrow Features
Figure 3. Epidermis Features
Figure 4. Global Autologous Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Neurology Case Studies
Figure 6. Orthopedics Case Studies
Figure 7. Cancer Case Studies
Figure 8. Wound Healing Case Studies
Figure 9. Other Case Studies
Figure 10. Autologous Cell Therapy Report Years Considered
Figure 11. Global Autologous Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Autologous Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Autologous Cell Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Autologous Cell Therapy Market Share by Players in 2019
Figure 16. Global Top Autologous Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Cell Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2019
Figure 18. North America Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Autologous Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. BioTime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BioTime Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 27. Pharmicell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pharmicell Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 29. BrainStorm Cell Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 31. Opexa Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Opexa Therapeutics Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 33. Vericel Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Vericel Corporation Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 35. Regeneus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Regeneus Revenue Growth Rate in Autologous Cell Therapy Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed